España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Small Pharma Inc
DMTTF
OTC
Watchlist
Get Report
Perks
Buy
Compare Brokers
$0.111700
0
0.00%
At close: Oct 20, 3:59 PM EDT
15 minutes delayed
Get Report
Watch
Small Pharma Inc (DMTTF) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Small Pharma Inc (OTC:DMTTF) Stock
Small Pharma Inc Stock (OTC: DMTTF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Saturday, January 06, 2024
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
Maureen Meehan
Monday, October 30, 2023
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoir And More
Lara Goldstein
Thursday, October 26, 2023
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
Lara Goldstein
Monday, October 23, 2023
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
Lara Goldstein
Sunday, October 22, 2023
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Lara Goldstein
Friday, October 20, 2023
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Lara Goldstein
Wednesday, October 18, 2023
Cybin's Acquisition Of Small Pharma Approved By Canadian Supreme Court
Lara Goldstein
Monday, October 16, 2023
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Lara Goldstein
Friday, October 13, 2023
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Lara Goldstein
Monday, October 02, 2023
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Lara Goldstein
Tuesday, September 26, 2023
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Lara Goldstein
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Lara Goldstein
Friday, September 22, 2023
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
Lara Goldstein
Monday, September 18, 2023
Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge
Lara Goldstein
Tuesday, September 05, 2023
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
Lara Goldstein
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Lara Goldstein
Thursday, August 31, 2023
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
Lara Goldstein
Tuesday, August 29, 2023
Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M
Lara Goldstein
Monday, August 28, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Lara Goldstein
Cybin To Acquire Small Pharma Inc.; Small Pharma Shareholders Will Receive 0.2409 Common Shares In The Capital Of Cybin; Exchange Ratio Implies Consideration Of ~$0.10 Per Small Pharma Share
Happy Mohamed
Thursday, August 03, 2023
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Lara Goldstein
Friday, July 28, 2023
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
Lara Goldstein
Tuesday, July 11, 2023
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Lara Goldstein
Wednesday, July 05, 2023
Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change
Lara Goldstein
Tuesday, July 04, 2023
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
Lara Goldstein
Thursday, June 29, 2023
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
Lara Goldstein
Wednesday, May 31, 2023
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Lara Goldstein
Friday, May 26, 2023
Small Pharma's IP Portfolio Grows With Numerous Approved Patent Applications Around The World
Lara Goldstein
Tuesday, April 04, 2023
Could DMT Therapy Be The Future Of Brain Injury Treatment? This Study Has Promising Results
Lara Goldstein
Tuesday, March 21, 2023
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
Lara Goldstein
Monday, March 13, 2023
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Lara Goldstein
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
Lara Goldstein
Wednesday, March 08, 2023
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
Lara Goldstein
Tuesday, February 21, 2023
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein
Wednesday, February 15, 2023
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
Lara Goldstein
Tuesday, February 07, 2023
HC Wainwright & Co. Reiterates Buy on Small P...
Benzinga Newsdesk
Wednesday, February 01, 2023
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
Lara Goldstein
Wednesday, January 25, 2023
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
Lara Goldstein
Wednesday, January 11, 2023
Comparing Psychedelics' Administration Routes: Are Intramuscular Injections More Effective Than Intravenous?
Lara Goldstein
Wednesday, December 28, 2022
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Lara Goldstein
Thursday, December 22, 2022
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Lara Goldstein
Monday, December 19, 2022
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
Lara Goldstein
Friday, December 16, 2022
How Certain Psychedelics Produce Brain And Behavior Changes: UCL Leads New Study
Lara Goldstein
Thursday, November 24, 2022
Psychedelic Stock Gainers And Losers From November 24, 2022
Benzinga Insights
Wednesday, November 23, 2022
Psychedelic Stock Gainers And Losers From November 23, 2022
Benzinga Insights
Tuesday, November 08, 2022
Psychedelic Stock Gainers And Losers From November 8, 2022
Benzinga Insights
Monday, November 07, 2022
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, November 03, 2022
Psychedelic Stock Gainers And Losers From November 3, 2022
Benzinga Insights
Wednesday, November 02, 2022
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, October 31, 2022
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
Lara Goldstein
Show More
